Swiss Sarcoma Network: Prediction Model for Patient Selection in Sarcoma Care
Sponsor: Kantonsspital Winterthur KSW · NCT04300257 on ClinicalTrials.gov ↗
Conditions studied
Where it's running8 sites
8 international sites
- Recruiting now
Kantonsspital Winterthur
Winterthur, Canton of Zurich, Switzerland 8400
- Stefan Breitenstein, Prof. Dr. med.(contact)+41 52 266 2121
- Bruno Fuchs, MD PhD(contact)+41 52 266 2121[email protected]
- Recruiting now
SwissSarcomaNetwork
Winterthur, Canton of Zurich, Switzerland 8400
- Larissa Slater(contact)+41 52 266 24 88[email protected]
- Recruiting now
Ente Ospedaliero Cantonale
Bellinzona, Canton Ticino, Switzerland 6500
- Silke Gillessen Sommer, Prof. Dr. med.(contact)+41 91 811 94 10
- Recruiting now
Kantonsspital Graubünden
Chur, Kanton Graubünden, Switzerland 7000
- Christian Michelitsch, Dr. med.(contact)+41 81 256 62 05
- Recruiting now
Luzerner Kantonsspital
Lucerne, Switzerland 6000
- Gabriela Studer, Prof. Dr. med.(contact)+41 41 205 58 01
- Recruiting now
Pathologie Institut Enge
Zurich, Switzerland 8005
- Beata Bode, Prof. Dr. med.(contact)+41 44 287 38 38
- Recruiting now
Klinik Hirslanden
Zurich, Switzerland 8032
- Paul Magnus Schneider, Prof. Dr.(contact)+41 44 387 31 66[email protected]
- Annelies Schnider, Dr. med.(contact)
- Recruiting now
Stadtspital Zürich Triemli
Zurich, Switzerland 8063
- Markus Weber, Prof. Dr. med. Dr. h.c.(contact)+41 44 416 43 01
See the official eligibility language
Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.
Inclusion Criteria: * Malignant and intermediate and selected benign bone or soft tissue tumors, acc. to the WHO coding list of the SSN * Female and male subjects of all ages Exclusion Criteria: * Documented objection of subsequent use of personal health data
Updated 2024-03-20 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.